162 related articles for article (PubMed ID: 22889954)
1. Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.
Furlan A; Lamballe F; Stagni V; Hussain A; Richelme S; Prodosmo A; Moumen A; Brun C; Del Barco Barrantes I; Arthur JS; Koleske AJ; Nebreda AR; Barilà D; Maina F
J Hepatol; 2012 Dec; 57(6):1292-8. PubMed ID: 22889954
[TBL] [Abstract][Full Text] [Related]
2. Met acts on Mdm2 via mTOR to signal cell survival during development.
Moumen A; Patané S; Porras A; Dono R; Maina F
Development; 2007 Apr; 134(7):1443-51. PubMed ID: 17329361
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.
Goldberg Z; Vogt Sionov R; Berger M; Zwang Y; Perets R; Van Etten RA; Oren M; Taya Y; Haupt Y
EMBO J; 2002 Jul; 21(14):3715-27. PubMed ID: 12110584
[TBL] [Abstract][Full Text] [Related]
4. Abl interconnects oncogenic Met and p53 core pathways in cancer cells.
Furlan A; Stagni V; Hussain A; Richelme S; Conti F; Prodosmo A; Destro A; Roncalli M; Barilà D; Maina F
Cell Death Differ; 2011 Oct; 18(10):1608-16. PubMed ID: 21455220
[TBL] [Abstract][Full Text] [Related]
5. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
[TBL] [Abstract][Full Text] [Related]
6. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.
Stepniak E; Ricci R; Eferl R; Sumara G; Sumara I; Rath M; Hui L; Wagner EF
Genes Dev; 2006 Aug; 20(16):2306-14. PubMed ID: 16912279
[TBL] [Abstract][Full Text] [Related]
7. C-Abl as a modulator of p53.
Levav-Cohen Y; Goldberg Z; Zuckerman V; Grossman T; Haupt S; Haupt Y
Biochem Biophys Res Commun; 2005 Jun; 331(3):737-49. PubMed ID: 15865930
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
[TBL] [Abstract][Full Text] [Related]
9. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
[TBL] [Abstract][Full Text] [Related]
10. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner.
Moumen A; Ieraci A; Patané S; Solé C; Comella JX; Dono R; Maina F
Hepatology; 2007 May; 45(5):1210-7. PubMed ID: 17464994
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
Sanchez-Prieto R; Sanchez-Arevalo VJ; Servitja JM; Gutkind JS
Oncogene; 2002 Jan; 21(6):974-9. PubMed ID: 11840343
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
[TBL] [Abstract][Full Text] [Related]
15. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
16. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
[TBL] [Abstract][Full Text] [Related]
17. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons.
Zhu Y; Mao XO; Sun Y; Xia Z; Greenberg DA
J Biol Chem; 2002 Jun; 277(25):22909-14. PubMed ID: 11948180
[TBL] [Abstract][Full Text] [Related]
18. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
[TBL] [Abstract][Full Text] [Related]
19. Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells.
Goetz AW; van der Kuip H; Maya R; Oren M; Aulitzky WE
Cancer Res; 2001 Oct; 61(20):7635-41. PubMed ID: 11606405
[TBL] [Abstract][Full Text] [Related]
20. Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress.
Lee JH; Jeong MW; Kim W; Choi YH; Kim KT
J Biol Chem; 2008 Jul; 283(28):19826-35. PubMed ID: 18490454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
